Infectious Diseases
From the Journals
Hypertension linked to risk of severe COVID
A new study out of the United Kingdom identifies at what level high blood pressure can help predict a life-threatening case of the virus.
News
‘A huge deal’: Millions have long COVID, and more are expected
More than a quarter say their condition is severe enough to significantly limit their day-to-day activities.
News from the FDA/CDC
Children and COVID: Weekly cases continue to hold fairly steady
The latest hospital admission data may be telling a somewhat different story.
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
News from the FDA/CDC
Children and COVID: New cases increase for second straight week
Extended declines in ED visits and hospitalizations may be reversing.
Feature
Man with COVID finally tests negative after 411 days
The man was treated with a mixture of neutralizing monoclonal antibodies.
News from the FDA/CDC
Mid-October flulike illness cases higher than past 5 years
The 2022-2023 season is already “gathering speed … about a month early,” one expert said.
From the Journals
‘Unappreciated’ ties between COVID and gut dysbiosis
“Now that we have uncovered the source of this bacterial imbalance, physicians can better identify those coronavirus patients most at risk of a...
News from the FDA/CDC
Children and COVID: Weekly cases can’t sustain downward trend
Hospitalizations and emergency department visits may be on the rise again.
From the Journals
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults...
Feature
Is it flu, RSV, or COVID? Experts fear the ‘tripledemic’
Predicting exactly when cases will peak is difficult.